Open access
Open access
Powered by Google Translator Translator

Chest Medicine

Randomized trial: Tocilizumab does not improve outcomes for patients hospitalized with Covid-19

22 Oct, 2020 | 09:42h | UTC

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 – New England Journal of Medicine

Commentary: Tocilizumab doesn’t ease symptoms or prevent death in moderately ill COVID-19 inpatients – Massachusetts General Hospital

 


New calculator predicts risk of hospital admission and mortality from coronavirus 19 in adults

22 Oct, 2020 | 09:37h | UTC

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study – The BMJ

See calculator: QCovid® risk calculator

 

Commentary on Twitter

 


Imaging features and differential diagnoses of non-neoplastic diffuse mediastinal diseases

22 Oct, 2020 | 09:26h | UTC

Imaging features and differential diagnoses of non-neoplastic diffuse mediastinal diseases – Insights into Imaging

 


ATS Conference coverage: Many patients prescribed home oxygen after an acute COPD exacerbation no longer meet the criteria two to three months later

22 Oct, 2020 | 09:25h | UTC

Breathing easier from hospital to home – ACP Internist

 


Studies offer little hope for Tocilizumab in treating COVID

21 Oct, 2020 | 09:27h | UTC

Studies offer little hope for tocilizumab in treating COVID – CIDRAP

See studies: Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 – JAMA Internal Medicine AND Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial – JAMA Internal Medicine AND Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial – JAMA Internal Medicine

Commentary: expert reaction to three studies of Tocilizumab to treat COVID patients – Science Media Centre

Related study (preprint): Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia – medRxiv

 


Studies point to big drop in COVID-19 death rates

21 Oct, 2020 | 09:23h | UTC

Studies Point To Big Drop In COVID-19 Death Rates – NPR

 


Podcast: Approach to shortness of breath

21 Oct, 2020 | 09:06h | UTC

#236 Physical Exam Series: Approach to Shortness of Breath – The Curbsiders Internal Medicine Podcast

 


Herd immunity and implications for SARS-CoV-2 control

20 Oct, 2020 | 01:44h | UTC

Herd Immunity and Implications for SARS-CoV-2 Control – JAMA

Author Interview: Can We Count on Herd Immunity to Control COVID-19? – JAMA

Patient Page: What Is Herd Immunity? – JAMA

 

Commentary on Twitter

 


Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?

20 Oct, 2020 | 01:38h | UTC

Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s? – Intensive Care Medicine

 

Commentary on Twitter

 


Meta-analysis: The association of D-dimers with mortality, intensive care unit admission or ARDS in patients hospitalized with COVID-19

20 Oct, 2020 | 01:37h | UTC

The association of D-dimers with mortality, intensive care unit admission or acute respiratory distress syndrome in patients hospitalized with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis – Heart & Lung

 


[Preprint] Multi-organ impairment in low-risk individuals with long COVID

18 Oct, 2020 | 23:18h | UTC

Multi-organ impairment in low-risk individuals with long COVID – medRxiv

Related study (preprint): Persistent symptoms after Covid-19: qualitative study of 114 long Covid patients and draft quality criteria for services – medRxiv

 

Commentary on Twitter

 


Improving prone positioning for severe ARDS during the COVID-19 pandemic: An implementation mapping approach

18 Oct, 2020 | 23:17h | UTC

Improving Prone Positioning for Severe ARDS during the COVID-19 Pandemic: An Implementation Mapping Approach – Annals of the American Thoracic Society

Commentary: Study examines ways to improve prone positioning for severe ARDS during COVID-19 pandemic – News Medical / American Thoracic Society

 

Commentary on Twitter

 


New studies show reduced prevalence and severity of SARS-CoV-2 infection in ABO blood group O

18 Oct, 2020 | 23:16h | UTC

Study 1: Reduced prevalence of SARS-CoV-2 infection in ABO blood group O – Blood Advances

Study 2: The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 – Blood Advances

Commentaries: People with blood type O may have lower risk of Covid-19 infection and severe illness, two new studies suggest – CNN AND Studies offer new evidence for possible link between blood type and COVID-19 susceptibility – American Society of Hematology

 


NIHR dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid)

18 Oct, 2020 | 23:14h | UTC

A dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid) – National Institute for Health Research

News Release: Living with COVID: NIHR publishes dynamic themed review into ‘ongoing COVID’

Commentaries: Coronavirus: ‘Long Covid could be four different syndromes’ – BBC AND Long covid could be four different syndromes, review suggests – The BMJ AND ‘Long COVID’ may affect multiple parts of body and mind, doctors say – Reuters

 


Acute Respiratory Distress Syndrome: Contemporary management and novel approaches during COVID-19

18 Oct, 2020 | 23:11h | UTC

Acute Respiratory Distress Syndrome: Contemporary Management and Novel Approaches during COVID-19 – Anesthesiology

Source: Grupo UTI Clínica HCFMUSP

 

Commentary on Twitter

 


Answering key questions about COVID-19 vaccines

18 Oct, 2020 | 23:10h | UTC

Answering Key Questions About COVID-19 Vaccines – JAMA

 

Commentary on Twitter

 


Cytokine elevation in severe and critical COVID-19: A rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

18 Oct, 2020 | 23:07h | UTC

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes – The Lancet Respiratory Medicine

 

Commentary on Twitter

 


[Preprint] WHO SOLIDARITY trial results published; Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon do not improve outcomes in Covid-19

16 Oct, 2020 | 09:42h | UTC

Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results – medRxiv

Commentary: Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments – Science

 

Commentaries on Twitter

 


Scientific consensus on the COVID-19 pandemic: we need to act now

16 Oct, 2020 | 09:41h | UTC

Scientific consensus on the COVID-19 pandemic: we need to act now – The Lancet

Commentary: Herd immunity approaches to COVID-19 control are a ‘dangerous fallacy’, say authors of open letter – The Lancet

 


Viewpoint: Sensible medicine—balancing intervention and inaction during the COVID-19 pandemic

16 Oct, 2020 | 09:38h | UTC

Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic – JAMA

Author interview: Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic

 

Commentary on Twitter

 


Cochrane living systematic review: Not enough evidence to recommend convalescent plasma for people with COVID‐19

16 Oct, 2020 | 09:34h | UTC

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review – Cochrane Library

 

Commentary on Twitter

 


Randomized trial: Effect of sustained smoking cessation counseling and free medication vs. shorter-term counseling and medication advice on smoking abstinence

16 Oct, 2020 | 09:23h | UTC

Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial – JAMA

Commentary: Long-term, frequent phone counseling helps cancer patients who smoke quit – eCancer

 


Updated Cochrane Review shows electronic cigarettes can help people quit smoking

16 Oct, 2020 | 09:21h | UTC

Updated Cochrane Review shows electronic cigarettes can help people quit smoking – Cochrane Library

Original study: Electronic cigarettes for smoking cessation – Cochrane Library

 

Commentary on Twitter

 


IDSA Position Statement: “Herd immunity” is not an answer to a pandemic

15 Oct, 2020 | 09:31h | UTC

“Herd Immunity” is Not an Answer to a Pandemic – Infectious Diseases Society of America

 

Commentary on Twitter

 


Review: The duration of infectiousness of individuals infected with SARS-CoV-2

15 Oct, 2020 | 09:26h | UTC

The duration of infectiousness of individuals infected with SARS-CoV-2 – Journal of Infection

 

Commentary on Twitter

 


Stay Updated in Your Specialty

 

No spam, just news.